Skip to main content

Aina Marti Carretero

Institutions of which they are part

Predoctoral researcher
Liver Diseases
Vall Hebron Institut de Recerca

Aina Marti Carretero

Institutions of which they are part

Predoctoral researcher
Liver Diseases
Vall Hebron Institut de Recerca

Related news

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

The research team used nanotechnology to deliver the drug directly to liver cells, which eliminated side effects without reducing effectiveness.

Related professionals

Altayo Carulla, Marta

Altayo Carulla, Marta

Research assistant
Reconstructive Surgery of the Locomotor System
Read more
Alberto Plaja Rustein

Alberto Plaja Rustein

Main researcher
Genetics Medicine
Read more
Soler Llongueras, Elisabet

Soler Llongueras, Elisabet

Administration and Management
Clinical Neuroimmunology
Read more
Méndez Soriano, Sara

Méndez Soriano, Sara

Physiology and Pathophysiology of the Digestive Tract
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.